Tue. Feb 27th, 2024

As it is achievable that other customers of the Mobile Adhesion Molecule (CAM) family can compensate for the role of CD166 in murine prostate cancer advancement, we are not able to conclude that CD166 has no in vivo function on prostate most cancers initiation

. Nonetheless, considering that cancer initiating cell area markers can be applied for molecular imaging and/or for internalizing a loss of life-inducing compound for focused therapies , our function suggests…